Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.
Br J Haematol. 2023 Apr;201(1):162-167. doi: 10.1111/bjh.18672. Epub 2023 Jan 31.
Br J Haematol. 2023.
PMID: 36720464
No abstract available.
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset.
Djebbari F, Rampotas A, Vallance G, Panitsas F, Basker N, Sangha G, Salhan B, Karim F, Al-Kaisi F, Gudger A, Ngu L, Poynton M, Lam HPJ, Morgan L, Yang L, Young J, Walker M, Tsagkaraki I, Anderson L, Chauhan SR, Maddams R, Soutar R, Triantafillou M, Prideaux S, Obeidalla A, Bygrave C, Basu S, Ramasamy K.
Djebbari F, et al. Among authors: lam hpj.
Hemasphere. 2022 May 26;6(6):e738. doi: 10.1097/HS9.0000000000000738. eCollection 2022 Jun.
Hemasphere. 2022.
PMID: 35651713
Free PMC article.
Item in Clipboard
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study.
Djebbari F, Rampotas A, Vallance G, Panitsas F, Basker N, Sangha G, Salhan B, Karim F, Firas AK, Gudger A, Ngu L, Poynton M, Lam HPJ, Morgan L, Yang L, Young J, Walker M, Tsagkaraki I, Anderson L, Chauhan SR, Maddams R, Soutar R, Triantafillou M, Prideaux S, Obeidalla A, Eyre TA, Bygrave C, Basu S, Ramasamy K.
Djebbari F, et al. Among authors: lam hpj.
Hematology. 2022 Dec;27(1):691-699. doi: 10.1080/16078454.2022.2082725.
Hematology. 2022.
PMID: 35666686
Item in Clipboard
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
Harrington P, Doores KJ, Radia D, O'Reilly A, Lam HPJ, Seow J, Graham C, Lechmere T, McLornan D, Dillon R, Shanmugharaj Y, Espehana A, Woodley C, Saunders J, Curto-Garcia N, O'Sullivan J, Raj K, Kordasti S, Malim MH, Harrison C, de Lavallade H.
Harrington P, et al. Among authors: lam hpj.
Br J Haematol. 2021 Sep;194(6):999-1006. doi: 10.1111/bjh.17568. Epub 2021 Jun 3.
Br J Haematol. 2021.
PMID: 34085278
Free PMC article.
Clinical Trial.
Item in Clipboard
Antibody drug conjugates for the treatment of multiple myeloma.
Leong S, Lam HPJ, Kirkham Z, Popat R.
Leong S, et al. Among authors: lam hpj.
Am J Hematol. 2023 Mar;98 Suppl 2:S22-S34. doi: 10.1002/ajh.26750. Epub 2022 Oct 24.
Am J Hematol. 2023.
PMID: 36199262
Free article.
Review.
Item in Clipboard
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
Harrington P, Doores KJ, Saunders J, de Lord M, Saha C, Lechmere T, Khan H, Lam HPJ, Reilly AO, Woodley C, Asirvatham S, Dillon R, Curto-Garcia N, Sullivan JO, Kordasti S, Raj K, Malim MH, Radia D, McLornan D, Harrison C, de Lavallade H.
Harrington P, et al. Among authors: lam hpj.
Blood Cancer J. 2022 Apr 22;12(4):73. doi: 10.1038/s41408-022-00651-3.
Blood Cancer J. 2022.
PMID: 35459222
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite